Skip to main content

Articles selected in February 2004

Articles selected from PubMed

References

  1. 1.

    Wang LH, Yang XY, Zhang X, Mihalic K, Fan YX, Xiao W, Howard OM, Appella E, Maynard AT, Farrar WL: Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. Nat Med. 2004, 10: 40-47.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Santen RJ, Song RX, Zhang Z, Yue W, Kumar R: Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer. Clin Cancer Res. 2004, 10: 337-345.

    Article  Google Scholar 

  3. 3.

    Nicholson RI, Hutcheson IR, Knowlden JM, Jones HE, Harper ME, Jordan N, Hiscox SE, Barrow D, Gee JM: Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clin Cancer Res. 2004, 10: 346-354.

    Article  Google Scholar 

  4. 4.

    Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA: Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA. 2004, 101: 1566-1571.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Kunzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR: Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer. J Natl Cancer Inst. 2004, 96: 210-218.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Holmberg L, Anderson H, for the HABITS steering and data monitoring committees: HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. The Lancet. 2004, 363: 453-455.

    CAS  Article  Google Scholar 

  7. 7.

    Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R: p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells. J Biol Chem. 2004, 279: 1422-1428.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Reiter R, Oh AS, Wellstein A, Riegel AT: Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta 3 on estrogenic ligands with different intrinsic activity. Oncogene. 2004, 23: 403-409.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Valerie Speirs.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Speirs, V. Articles selected in February 2004 . Breast Cancer Res 6, E12 (2004). https://doi.org/10.1186/bcr769

Download citation

Keywords

  • Cancer Research